Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Dec;83(12):1366-72.
doi: 10.1111/j.1349-7006.1992.tb02771.x.

Establishment of an enzyme immunoassay using monoclonal antibody (HG1-219) and its application for the diagnosis of hepatocellular carcinoma

T Hada  1 , Y Kinoshita, Y Ichimori, H Imanishi, K Umeyama, Y Amuro, A Toyosaka, E Okamoto, K Higashino
Affiliations

Establishment of an enzyme immunoassay using monoclonal antibody (HG1-219) and its application for the diagnosis of hepatocellular carcinoma

T Hada et al. Jpn J Cancer Res. 1992 Dec.

Abstract

A monoclonal antibody (MoAb HG1-219) against a human gastric cancer cell line (HuG-1) and its shedding antigen (HG1-219 Ag) was generated and a solid-phase sandwich enzyme immunoassay (EIA-219) was developed. The mean serum HG1-219 Ag concentration in normal individuals was 30.5 +/- 14.5 U/ml measured by EIA-219. When the mean +3 SD of the antigen concentration in normal individuals was used as a cut-off level, 4.3% (2/47) of patients with chronic hepatitis, 9.1% (4/44) of cirrhotic patients and 37.5% (18/48) of patients with hepatocellular carcinoma (HCC) had HG1-219 Ag above the cut-off value. The positive rates of a-fetoprotein (AFP) (> 400 ng/ml) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) for HCC were 26.7% (12/45) and 33.3% (12/36), respectively. There was no significant correlation between HG1-219 Ag and AFP or PIVKA-II in patients with HCC. The combination assay of EIA-219, AFP and PIVKA-II for HCC gave the positive rate of 75% (27/36). The effect of periodic acid on the HG1-219 Ag and the inhibition of EIA-219 by CA 19-9 suggest that the epitope of HG1-219 Ag is a suger chain similar to CA 19-9.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. ) Chen , D.‐S. and Sung , J.‐L.Serum alphafetoprotein in hepatocellular carcinoma . Cancer , 40 , 779 – 783 ( 1977. ). - PubMed
    1. ) Sawabu , N. , Wakabayashi , T. , Ozaki , K. , Taga , D. , Yoneshima , M. , Kadani , H. , Hattori , N. , and Ishii , M.Serum tumor markers in patients with hepatocellular carcinoma. Diagnosis of a‐fetoprotein‐low or ‐negative patients . Gastroenterol Jpn. , 20 , 210 – 215 ( 1985. ). - PubMed
    1. ) Tamura , S. , Amuro , Y. , Nakaoka , H. , Fujii , J. , Moriwaki , Y. , Yamamoto , T. , Hada , T. and Higashino , K.Urinary pseudouridine in patients with hepatocellular carcinoma . Cancer , 57 , 1573 – 1575 ( 1986. ). - PubMed
    1. ) Liebman , H. A. , Furie , B. C. , Tong , M. J. , Blanchard , R. A. , Lo , K.‐J. , Coleman , M. S. and Furie , B.Des‐/‐carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma . N. Engl. J. Med. , 310 , 1427 – 1431 ( 1984. ). - PubMed
    1. ) Kodama , T. , Yokoi , T. , Arima , K. , Suga , M. , Imai , K. , Yachi , A. , Takahashi , A. and Shimamura , Y.Clinical significance of abnormal prothrombin (PIVKA‐II) in the plasma of patients with hepatocellular carcinoma . Tumor Res. , 22 , 63 – 70 ( 1987. ).

LinkOut - more resources